Coloplast announced it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to “strategically strengthen [its] presence in the advanced ...
Comparing Coloplast to ConvaTec, the latter has been seeing double-digit growth in China, where Coloplast has been struggling ...
Coloplast is a leading global supplier of intimate healthcare products with a strong product portfolio and high market share. The company has a stable business model and benefits from demographic ...
The Centers for Medicare and Medicaid Services, or CMS, issued its final rule on the local coverage determination, or LCD, for skin substitutes and has included Coloplast's Kerecis (fish skin) for ...
Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback